India aligns with shift in global guidelines for influenza vaccination, urgent need to prioritise preventives
Transition in accordance with WHO recommendation for flu vaccination Bengaluru, India, 23rd August, 2025 :...
Tag : Zydus
Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg
Bengaluru, – 09 August, 2025 : Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred...
Zydus receives NOC from Health Canada for ZDS-Varenicline Tablets 0.5 &1 mg
This is the group’s first NoC approval in Canada Bengaluru, August 7, 2025 : Zydus...
Zydus gets exclusive licensing rights for next gen immuno-oncology platforms from the US based Agenus
Bengaluru, June 3, 2025 : Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as...
Zydus Lifesciences launches ANVIMO, a breakthrough for transplant patients
Made-in-India for India, ANVIMO brings access and affordability Bengaluru – 5 March, 2025 : Zydus,...
Zydus and Beihai Biotech sign an exclusive licensing
Zydus and Beihai Biotech sign an exclusive licensing, supply and commercialization agreement for BEIZRAY (Albumin...
Zydus and Synthon sign an exclusive development, licensing, supply and commercialization agreement for a novel 505(B)(2) oncology product for the US market
Bengaluru, February 12, 2025 : Zydus Lifesciences Ltd. (including its subsidiaries and affiliates), a global...
Zydus announces agreement with CVS Caremark to add ZituvioTM, ZituvimetTM and ZituvimetTM XR (Sitagliptin | Sitagliptin and Metformin Hydrochloride) to its template formulary
Bengaluru, 07 January, 2025 : Zydus Lifesciences Ltd. (including its subsidiaries/affiliates, hereafter referred to as ‘Zydus’), a...
Zydus Wellness Ltd posts Net Sales of Rs. 438 crores
For the second quarter ended September 30, 2023, Zydus Wellness Ltd. reported consolidated Net sales...